Clinical trial

Dapagliflozin + Saxagliptin in a Basal-bolus Insulin Treatment

NCT02965443

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2018-02-02

PhasePHASE4

Study timeline

Study start (actual)2018-02-02Date precision: day

Registry last updated2020-02-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

Dapagliflozin 10 mg + Saxagliptin 5 mgDRUG

Placebo 1 10 mg + Placebo 2 5 mgDRUG

Sponsors & collaborators

University Hospital Tuebingenlead sponsor

Mapped research locations

TübingenGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02965443 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.